Skin barrier

Life-Threatening Dermatoses and Emergencies in Dermatology

Volumn , Issue , 2009, Pages 3-18

  Fluhr, Joachim W ^a   Darlenski, Razvigor ^b  

^a Bioskin   (Germany)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80755179493     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-79339-7_1     Document Type: Chapter

References (140)

1. Merriam-Webster Online Dictionary, 2007.
2. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007; 39: 650-4.
3. Williams ML, Hanley K, Elias PM, et al. Ontogeny of the epidermal permeability barrier. J Investig Dermatol Symp Proc 1998; 3: 75-9.
4. Elias PM, Choi EH. Interactions among stratum corneum defensive functions. Exp Dermatol 2005; 14: 719-26.
5. Aberg KM, Radek KA, Choi EH, et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest 2007; 117: 3339-49.
6. Gieler U, Niemeier V, Kupfer J, et al. Psychosomatic dermatology in Germany: a survey of 69 dermatologic clinics. Hautarzt 2001; 52: 104-10.
7. Harding CR. The stratum corneum: structure and function in health and disease. Dermatol Ther 2004; 17(1): 6-15.
8. Saurat JH. Dermatoporosis: the functional side of skin aging. Dermatology 2007; 215: 271-2.
9. Kalia YN, Nonato LB, Lund CH, et al. Development of skin barrier function in premature infants. J Invest Dermatol 1998; 111: 320-6.
10. Fluhr JW, Elias PM. Stratum corneum (SC) pH: formation and function of the "acid mantle". Exog. Dermatol. 2002; 1: 163-75.
11. Atherton DJ. The aetiology and management of irritant diaper dermatitis. J Eur Acad Dermatol Venereol 2001; 15(1): 1-4.
12. Feingold KR. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 2007; 48: 2531-46.
13. Bouwstra JA, Gooris GS, Dubbelaar FE, et al. Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res 1998; 39: 186-96.
14. Wertz PW, Downing DT. Covalently bound omega-hydroxyacylsphingosine in the stratum corneum. Biochim Biophys Acta 1987; 917: 108-11.
15. Mao-Qiang M, Jain M, Feingold KR, et al. Secretory phospholipase A2 activity is required for permeability barrier homeostasis. J Invest Dermatol 1996; 106: 57-63.
16. Forslind B. A domain mosaic model of the skin barrier. Acta Derm Venereol 1994; 74: 1-6.
17. Bouwstra JA, Dubbelaar FE, Gooris GS, et al. The lipid organisation in the skin barrier. Acta Derm Venereol Suppl (Stockh) 2000; 208: 23-30.
18. Norlen L. Skin barrier structure and function: the single gel phase model. J Invest Dermatol 2001; 117: 830-6.
19. Tanaka T, Ogura R, Hidaka T, et al. Changes of electron spin resonance membrane fluidity in hexadecane-induced hyperproliferative epidermis. J Invest Dermatol 1989; 93: 682-6.
20. Bouwstra JA, Gooris GS, Dubbelaar FE, et al. Phase behavior of stratum corneum lipid mixtures based on human ceramides: the role of natural and synthetic ceramide 1. J Invest Dermatol 2002; 118: 606-17.
21. Elias P, Feingold K. Permeability barrier homeostasis. In: Skin barrier (Elias PM, Feingold KR, eds). New York: Taylor & Francis. 2006; 337-61.
22. Sprecher E, Ishida-Yamamoto A, Becker OM, et al. Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix. J Invest Dermatol 2001; 116: 511-9.
23. Rawlings AV, Matts PJ. Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle. J Invest Dermatol 2005; 124: 1099-110.
24. Pearton DJ, Dale BA, Presland RB. Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution. J Invest Dermatol 2002; 119: 661-9.
25. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-40.
26. Steven AC, Steinert PM. Protein composition of cornified cell envelopes of epidermal keratinocytes. J Cell Sci 1994; 107(Pt 2): 693-700.
27. Schmuth M, Fluhr JW, Crumrine DC, et al. Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis). J Invest Dermatol 2004; 122: 909-22.
28. Jeon S, Djian P, Green H. Inability of keratinocytes lacking their specific transglutaminase to form cross-linked envelopes: absence of envelopes as a simple diagnostic test for lamellar ichthyosis. Proc Natl Acad Sci U S A 1998; 95: 687-90.
29. Nemes Z, Marekov LN, Steinert PM. Involucrin cross-linking by transglutaminase 1. Binding to membranes directs residue specificity. J Biol Chem 1999; 274: 11013-21.
30. Simon M, Jonca N, Guerrin M, et al. Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem 2001; 276: 20292-9.
31. Hachem JP, Crumrine D, Fluhr J, et al. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003; 121: 345-53.
32. Menon GK, Elias PM. Morphologic basis for a pore-pathway in mammalian stratum corneum. Skin Pharmacol 1997; 10: 235-46.
33. Furuse M, Hata M, Furuse K, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002; 156: 1099-111.
34. Turksen K, Troy TC. Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development 2002; 129: 1775-84.
35. Barak O, Treat JR, James WD. Antimicrobial peptides: effectors of innate immunity in the skin. Adv Dermatol 2005; 21: 357-74.
36. Elias PM. The skin barrier as an innate immune element. Semin Immunopathol 2007; 29: 3-14.
37. Aberg KM, Man MQ, Gallo RL, et al. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 2008; 128(4): 917-25.
38. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-60.
39. Denda M, Tsuchiya T, Elias PM, et al. Stress alters cutaneous permeability barrier homeostasis. Am J Physiol Regul Integr Comp Physiol 2000; 278: R367-72.
40. Choi EH, Brown BE, Crumrine D, et al. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 2005; 124: 587-95.
41. Arck PC, Slominski A, Theoharides TC, et al. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006; 126: 1697-704.
42. Warner RR, Myers MC, Taylor DA. Electron probe analysis of human skin: determination of the water concentration profile. J Invest Dermatol 1988; 90: 218-24.
43. Caspers PJ, Lucassen GW, Carter EA, et al. In vivo confocal Raman microspectroscopy of the skin: noninvasive determination of molecular concentration profiles. J Invest Dermatol 2001; 116: 434-42.
44. Rawlings AV. Sources and role of stratum corneum hydration. In: Skin barrier (Elias PM, Feingold KR, eds). New York: Taylor & Francis. 2006; 399-425.
45. Wildnauer RH, Bothwell JW, Douglass AB. Stratum corneum biomechanical properties. I. Influence of relative humidity on normal and extracted human stratum corneum. J Invest Dermatol 1971; 56: 72-8.
46. Madison KC. Barrier function of the skin: "la raison d'etre" of the epidermis. J Invest Dermatol 2003; 121: 231-41.
47. Rawlings AV. Trends in stratum corneum research and the management of dry skin conditions. Int J Cosmetic Sci 2003; 25: 63-95.
48. Imokawa G, Kuno H, Kawai M. Stratum corneum lipids serve as a bound-water modulator. J Invest Dermatol 1991; 96: 845-51.
49. Caspers PJ, Lucassen GW, Puppels GJ. Combined in vivo confocal Raman spectroscopy and confocal microscopy of human skin. Biophys J 2003; 85: 572-80.
50. Scott IR, Harding CR. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 1986; 115: 84-92.
51. Boeshans KM, Mueser TC, Ahvazi B. A three-dimensional model of the human transglutaminase 1: insights into the understanding of lamellar ichthyosis. J Mol Model 2007; 13: 233-46.
52. Ashida Y, Ogo M, Denda M. Epidermal interleukin-1 alpha generation is amplified at low humidity: implications for the pathogenesis of inflammatory dermatoses. Br J Dermatol 2001; 144: 238-43.
53. Wood LC, Elias PM, Calhoun C, et al. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 1996; 106: 397-403.
54. Denda M, Sato J, Masuda Y, et al. Exposure to a dry environment enhances epidermal permeability barrier function. J Invest Dermatol 1998; 111: 858-63.
55. Sato J, Denda M, Chang S, et al. Abrupt decreases in environmental humidity induce abnormalities in permeability barrier homeostasis. J Invest Dermatol 2002; 119: 900-4.
56. Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for bloodbrain barrier disruption after stroke. Stroke 2002; 33: 1706-11.
57. Cornelissen LH, Oomens CW, Huyghe JM, et al. Mechanisms that play a role in the maintenance of the calcium gradient in the epidermis. Skin Res Technol 2007; 13: 369-76.
58. Mao-Qiang M, Mauro T, Bench G, et al. Calcium and potassium inhibit barrier recovery after disruption, independent of the type of insult in hairless mice. Exp Dermatol 1997; 6: 36-40.
59. Choi EH, Kim MJ, Yeh BI, et al. Iontophoresis and sonophoresis stimulate epidermal cytokine expression at energies that do not provoke a barrier abnormality: lamellar body secretion and cytokine expression are linked to altered epidermal calcium levels. J Invest Dermatol 2003; 121: 1138-44.
60. Furukawa F, Fujii K, Horiguchi Y, et al. Roles of E- and P-cadherin in the human skin. Microscopy Res Tech 1997; 38: 343-52.
61. Ahn BK, Jeong SK, Lee SH. Role of PKC-delta as a signal mediator in epidermal barrier homeostasis. Arch Dermatol Res 2007; 299: 53-7.
62. Ahn BK, Jeong SK, Kim HS, et al. Rottlerin, a specific inhibitor of protein kinase C-delta, impedes barrier repair response by increasing intracellular free calcium. J Invest Dermatol 2006; 126: 1348-55.
63. Elias PM, Crumrine D, Rassner U, et al. Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 2004; 122: 314-9.
64. Menon GK, Elias PM. Ultrastructural localization of calcium in psoriatic and normal human epidermis. Arch Dermatol 1991; 127: 57-63.
65. Elias PM, Feingold KR. Coordinate regulation of epidermal differentiation and barrier homeostasis. Skin Pharmacol Appl Skin Physiol 2001; 14(1): 28-34.
66. Kao JS, Fluhr JW, Man MQ, et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003; 120: 456-64.
67. Zouboulis CC, Chen WC, Thornton MJ, et al. Sexual hormones in human skin. Horm Metab Res 2007; 39: 85-95.
68. Schmuth M, Schoonjans K, Yu QC, et al. Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero. J Invest Dermatol 2002; 119: 1298-303.
69. Hanley K, Komuves LG, Ng DC, et al. Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha. J Biol Chem 2000; 275: 11484-91.
70. Sheu MY, Fowler AJ, Kao J, et al. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 2002; 118: 94-101.
71. Fowler AJ, Sheu MY, Schmuth M, et al. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol 2003; 120: 246-55.
72. Fluhr JW, Crumrine D, Mao-Qiang M, et al. Topical liver X receptor activators accelerate postnatal acidification of stratum corneum and improve function in the neonate. J Invest Dermatol 2005; 125: 1206-14.
73. Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 2006; 19: 296-302.
74. Puhvel SM, Reisner RM, Sakamoto M. Analysis of lipid composition of isolated human sebaceous gland homogenates after incubation with cutaneous bacteria. Thin-layer chromatography. J Invest Dermatol 1975; 64: 406-11.
75. Ament W, Huizenga JR, Mook GA, et al. Lactate and ammonia concentration in blood and sweat during incremental cycle ergometer exercise. Int J Sports Med 1997; 18: 35-9.
76. Krien PM, Kermici M. Evidence for the existence of a selfregulated enzymatic process within the human stratum corneum - an unexpected role for urocanic acid. J Invest Dermatol 2000; 115: 414-20.
77. Fluhr JW, Kao J, Jain M, et al. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001; 117: 44-51.
78. Behne MJ, Meyer JW, Hanson KM, et al. NHE1 regulates the stratum corneum permeability barrier homeostasis. Microenvironment acidification assessed with fluorescence lifetime imaging. J Biol Chem 2002; 277: 47399-406.
79. Fluhr JW, Mao-Qiang M, Brown BE, et al. Functional consequences of a neutral pH in neonatal rat stratum corneum. J Invest Dermatol 2004; 123: 140-51.
80. Hardman MJ, Sisi P, Banbury DN, et al. Patterned acquisition of skin barrier function during development. Development 1998; 125: 1541-52.
81. Visscher MO, Chatterjee R, Munson KA, et al. Changes in diapered and nondiapered infant skin over the first month of life. Pediatr Dermatol 2000; 17: 45-51.
82. Fluhr JW, Behne MJ, Brown BE, et al. Stratum corneum acidification in neonatal skin: secretory phospholipase A2 and the sodium/hydrogen antiporter-1 acidify neonatal rat stratum corneum. J Invest Dermatol 2004; 122: 320-9.
83. Leyden JJ, Kligman AM. The role of microorganisms in diaper dermatitis. Arch Dermatol 1978; 114: 56-9.
84. Mauro T, Holleran WM, Grayson S, et al. Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 1998; 290: 215-22.
85. Hachem JP, Man MQ, Crumrine D, et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 2005; 125: 510-20.
86. Bouwstra JA, Gooris GS, Dubbelaar FE, et al. Cholesterol sulfate and calcium affect stratum corneum lipid organization over a wide temperature range. J Lipid Res 1999; 40: 2303-12.
87. Komatsu N, Saijoh K, Sidiropoulos M, et al. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. J Invest Dermatol 2005; 125: 1182-9.
88. Egelrud T. Desquamation in the stratum corneum. Acta Derm Venereol Suppl (Stockh) 2000; 208: 44-5.
89. Korting HC, Hubner K, Greiner K, et al. Differences in the skin surface pH and bacterial microflora due to the long-term application of synthetic detergent preparations of pH 5.5 and pH 7.0. Results of a crossover trial in healthy volunteers. Acta Derm Venereol 1990; 70: 429-31.
90. Pinnagoda J, Tupker RA, Smit JA, et al. The intra- and interindividual variability and reliability of transepidermal water loss measurements. Contact Dermatitis 1989; 21: 255-9.
91. Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000; 25: 522-9.
92. Fennessy M, Coupland S, Popay J, et al. The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research. J Epidemiol Community Health 2000; 54: 581-9.
93. Thune P. Evaluation of the hydration and the water-holding capacity in atopic skin and so-called dry skin. Acta Derm Venereol Suppl (Stockh) 1989; 144: 133-5.
94. Berardesca E, Fideli D, Borroni G, et al. In vivo hydration and water-retention capacity of stratum corneum in clinically uninvolved skin in atopic and psoriatic patients. Acta Derm Venereol 1990; 70: 400-4.
95. Loden M, Olsson H, Axell T, et al. Friction, capacitance and transepidermal water loss (TEWL) in dry atopic and normal skin. Br J Dermatol 1992; 126: 137-41.
96. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
97. Angelova-Fischer I, Bauer A, Hipler UC, et al. The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis. Br J Dermatol 2005; 153: 767-73.
98. Sugarman JL, Fluhr JW, Fowler AJ, et al. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 2003; 139: 1417-22.
99. Imokawa G. Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol 2001; 45: S29-32.
100. Imokawa G, Abe A, Jin K, et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96: 523-6.
101. Tanno O, Ota Y, Kitamura N, et al. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol 2000; 143: 524-31.
102. Di Nardo A, Wertz P, Giannetti A, et al. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998; 78: 27-30.
103. Okamoto R, Arikawa J, Ishibashi M, et al. Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. J Lipid Res 2003; 44: 93-102.
104. Ishibashi M, Arikawa J, Okamoto R, et al. Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis. Lab Invest 2003; 83: 397-408.
105. Higuchi K, Hara J, Okamoto R, et al. The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 2000; 350(Pt 3): 747-56.
106. Hara J, Higuchi K, Okamoto R, et al. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 2000; 115: 406-13.
107. Fartasch M, Bassukas ID, Diepgen TL. Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 1992; 127: 221-7.
108. Arikawa J, Ishibashi M, Kawashima M, et al. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002; 119: 433-9.
109. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-6.
110. Weidinger S, Illig T, Baurecht H, et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006; 118: 214-9.
111. Fartasch M. Ultrastructure of the epidermal barrier after irritation. Microsc Res Tech 1997; 37: 193-9.
112. Ponec M, Kempenaar J. Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacol 1995; 8: 49-59.
113. Feingold KR, Schmuth M, Elias PM. The regulation of permeability barrier homeostasis. J Invest Dermatol 2007; 127: 1574-6.
114. Teichmann A, Jacobi U, Waibler E, et al. An in vivo model to evaluate the efficacy of barrier creams on the level of skin penetration of chemicals. Contact Dermatitis 2006; 54: 5-13.
115. Oumeish OY, Oumeish I. Life-threatening environmental dermatoses and agents of mass destruction with serious systemic consequences. Clin Dermatol 2005; 23: 276-84.
116. Santmyire-Rosenberger BR, Nigra TP. Psoriasis herpeticum: three cases of Kaposi's varicelliform eruption in psoriasis. J Am Acad Dermatol 2005; 53: 52-6.
117. Amagai M, Matsuyoshi N, Wang ZH, et al. Toxin in bullous impetigo and staphylococcal scalded skin syndrome targets desmoglein 1. Nat Med 2000; 6: 1275-7.
118. Amagai M, Yamaguchi T, Hanakawa Y, et al. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. J Invest Dermatol 2002; 118: 845-50.
119. Nishifuji K, Sugai M, Amagai M. Staphylococcal exfoliative toxins: "Molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci 2008; 49: 21-31.
120. Hanakawa Y, Stanley JR. Mechanisms of blister formation by staphylococcal toxins. J Biochem 2004; 136: 747-50.
121. Travers JB, Leung DY, Johnson C, et al. Augmentation of staphylococcal alpha-toxin signaling by the epidermal platelet-activating factor receptor. J Invest Dermatol 2003; 120: 789-94.
122. Aufiero B, Guo M, Young C, et al. Staphylococcus aureus induces the expression of tumor necrosis factor-alpha in primary human keratinocytes. Int J Dermatol 2007; 46: 687-94.
123. Hachem JP, Wagberg F, Schmuth M, et al. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 2006; 126: 1609-21.
124. Fartasch M, Williams ML, Elias PM. Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol 1999; 135: 823-32.
125. Sachs B, Fischer-Barth W, Erdmann S, et al. Anaphylaxis and toxic epidermal necrolysis or Stevens-Johnson syndrome after nonmucosal topical drug application: fact or fiction? Allergy 2007; 62: 877-83.
126. Teshima D, Ikesue H, Itoh Y, et al. Increased topical tacrolimus absorption in generalized leukemic erythroderma. Ann Pharmacother 2003; 37: 1444-7.
127. Pianigiani E, Ierardi F, Taddeucci P, et al. Skin allograft in the treatment of toxic epidermal necrolysis (TEN). Dermatol Surg 2002; 28: 1173-6.
128. Pinnagoda J, Tupker RA, Agner T, et al. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990; 22: 164-78.
129. Rogiers V. EEMCO guidance for the assessment of transepidermal water loss in cosmetic sciences. Skin Pharmacol Appl Skin Physiol 2001; 14: 117-28.
130. Smith HR, Rowson M, Basketter DA, et al. Intra-individual variation of irritant threshold and relationship to transepidermal water loss measurement of skin irritation. Contact Dermatitis 2004; 51: 26-9.
131. Tupker RA. Prediction of irritancy in the human skin irritancy model and occupational setting. Contact Dermatitis 2003; 49: 61-9.
132. Fluhr JW, Kuss O, Diepgen T, et al. Testing for irritation with a multifactorial approach: comparison of eight noninvasive measuring techniques on five different irritation types. Br J Dermatol 2001; 145: 696-703.
133. Villarama CD, Maibach H. Sensitive skin and transepidermal water loss. In: Bioengeneering of the Skin: Water and Stratum corneum, Second Edition (Fluhr JW, Elsner P, Berardesca E et al., eds). West Palm Beach: CRC. 2004.
134. Caspers PJ, Williams AC, Carter EA, et al. Monitoring the penetration enhancer dimethyl sulfoxide in human stratum corneum in vivo by confocal Raman spectroscopy. Pharm Res 2002; 19: 1577-80.
135. Pudney PD, Melot M, Caspers PJ, et al. An in vivo confocal Raman study of the delivery of trans retinol to the skin. Appl Spectrosc 2007; 61: 804-11.
136. Breternitz M, Flach M, Prassler J, et al. Acute barrier disruption by adhesive tapes is influenced by pressure, time and anatomical location: integrity and cohesion assessed by sequential tape stripping. A randomized, controlled study. Br J Dermatol 2007; 156: 231-40.
137. Fluhr JW, Kao J, Jain M, et al. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001; 117: 44-51.
138. Thiele JJ, Traber MG, Polefka TG, et al. Ozone-exposure depletes vitamin E and induces lipid peroxidation in murine stratum corneum. J Invest Dermatol 1997; 108: 753-7.
139. Kawakami S, Callicott RH, Zhang N. Trace analysis of benzalkonium chloride on skin by flow injection ionspray mass spectrometry-mass spectrometry. Analyst 1998; 123: 489-91.
140. De Paepe K, Janssens K, Hachem JP, et al. Squamometry as a screening method for the evaluation of hydrating products. Skin Res Technol 2001; 7: 184-92.